ES2976470T3 - Comprimidos bucodispersables de zonisamida - Google Patents

Comprimidos bucodispersables de zonisamida Download PDF

Info

Publication number
ES2976470T3
ES2976470T3 ES20808117T ES20808117T ES2976470T3 ES 2976470 T3 ES2976470 T3 ES 2976470T3 ES 20808117 T ES20808117 T ES 20808117T ES 20808117 T ES20808117 T ES 20808117T ES 2976470 T3 ES2976470 T3 ES 2976470T3
Authority
ES
Spain
Prior art keywords
zonisamide
disintegration
less
weight
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES20808117T
Other languages
English (en)
Spanish (es)
Inventor
Orazio Luca Strusi
Montserrat Coderch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noucor Health S A
Original Assignee
Noucor Health S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noucor Health S A filed Critical Noucor Health S A
Application granted granted Critical
Publication of ES2976470T3 publication Critical patent/ES2976470T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES20808117T 2019-11-22 2020-11-20 Comprimidos bucodispersables de zonisamida Active ES2976470T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19383034 2019-11-22
PCT/EP2020/082809 WO2021099531A1 (en) 2019-11-22 2020-11-20 Zonisamide orodispersible tablets

Publications (1)

Publication Number Publication Date
ES2976470T3 true ES2976470T3 (es) 2024-08-01

Family

ID=68808236

Family Applications (1)

Application Number Title Priority Date Filing Date
ES20808117T Active ES2976470T3 (es) 2019-11-22 2020-11-20 Comprimidos bucodispersables de zonisamida

Country Status (5)

Country Link
EP (1) EP4061328B1 (https=)
JP (1) JP7650274B2 (https=)
ES (1) ES2976470T3 (https=)
PT (1) PT4061328T (https=)
WO (1) WO2021099531A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024090218A (ja) * 2022-12-22 2024-07-04 ダイト株式会社 崩壊遅延を改善したゾニサミド含有口腔内速崩壊錠
AU2024227385A1 (en) * 2024-03-28 2025-10-16 Athena Pharmaceutiques Sas Lisdexamfetamine dimesylate orodispersible tablet and process for preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4989733B2 (ja) 2008-02-13 2012-08-01 大日本住友製薬株式会社 口腔内崩壊錠
JP5680898B2 (ja) 2010-08-10 2015-03-04 京都薬品工業株式会社 苦味を抑制した速崩壊錠
JP6230539B2 (ja) 2012-09-20 2017-11-15 株式会社ダイセル 酸型カルボキシメチルセルロース及び結晶セルロースを含む崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤
JP6271802B1 (ja) 2017-09-28 2018-01-31 武田テバファーマ株式会社 口腔内崩壊錠

Also Published As

Publication number Publication date
PT4061328T (pt) 2024-04-08
EP4061328A1 (en) 2022-09-28
JP7650274B2 (ja) 2025-03-24
JP2023502738A (ja) 2023-01-25
EP4061328B1 (en) 2024-01-03
WO2021099531A1 (en) 2021-05-27

Similar Documents

Publication Publication Date Title
EP2842549B1 (en) Orally disintegrating tablet and method for producing same
KR101438071B1 (ko) 약학 조성물
ES3006182T3 (en) Pharmaceutical composition, comprising phosphate binder particles
CN104023712B (zh) 高硬度快速崩解片及其制备方法
Pandey et al. Oral disintegrating tablets: a review
BR112015008139B1 (pt) Formulação de forma de dosagem sólida de desintegração rápida compreendendo carbonato de cálcio funcionalizado e método de fabricação dos mesmos
ES2976470T3 (es) Comprimidos bucodispersables de zonisamida
Roshan et al. Orodispersible tablets: A compendious review
Nagar et al. Cinnarizine orodispersible tablets: a chitosan based fast mouth dissolving technology
Khan et al. An approach for rapid disintegrating tablet: a review
JP4446177B2 (ja) 耐湿性口腔内崩壊錠の製造方法
JP5204976B2 (ja) イグラチモドを含有する速崩壊性錠剤
KR20130076511A (ko) 환경에 민감한 약물에 적합한 속붕정 및 이의 제조 방법
US8906949B2 (en) Orally disintegrating tablets of zolmitriptan and process for preparing the same
Vora et al. Oral dispersible tablet: A popular growing technology
WO2025229501A1 (es) Composición farmacéutica que comprende enalapril maleato, uso y proceso de preparación
Kumar et al. Development and characterization of melt-in-mouth tablets of haloperidol by sublimation technique
M Lokade et al. Formulation and evaluation of orodispersible tablet for anti-asthamatic drug
Thapliyal et al. Orodispersible tablets: A review
KR101593911B1 (ko) 높은 경도를 갖는 속붕정 및 이의 제조 방법
Magar Formulation and evalution of oral dispersible tablets
JP2011213695A (ja) ドネペジル塩酸塩含有口腔内速崩壊錠
Rai et al. A REVIEW ON: ORAL DISPERSIBLE TABLETS
Dhakal et al. Research Article Formulation of Ebastine Fast-Disintegrating Tablet Using Coprocessed Superdisintegrants and Evaluation of Quality Control Parameters
Jangid et al. DISPERSIBLE TABLET AS A FORMULATION FOR ORAL DRUG DELIVERY SYSTEM